Phaos Technology Holdings (Cayman) Limited
Phaos Technology Holdings (Cayman) Limited is a Cayman Islands-incorporated investment holding company headquartered in Singapore. Through its subsidiary, the company develops, assembles, and commercializes advanced microscopy-related solutions, technologies, and products for industrial, biomedical, and research applications. Its portfolio includes imaging and measurement systems such as Optonano, PT-Industrial, PT-Metrology, PT-Biology, PT-Stereo, and PT-Zoom, alongside proprietary software that supports image analysis, dimensional measurement, inspection, and workflow integration. Phaos Technology serves customers in manufacturing, biomedical services, and research and development, with distribution networks across Singapore, Vietnam, and other parts of Southeast Asia and South Asia. The company focuses on combining optical hardware with software capabilities to deliver microscopy tools used for quality control, material study, failure analysis, and specialized imaging needs.
$2.60
+$0.44 (+20.42%)
EOD Oct 16, 2026
The business is unprofitable at the operating level (-4771.24% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 21.2% YoY. Margins deteriorated 2389.9pp alongside, both lines moving the wrong way.
ROIC dropped from -158.60% to -165.47%, capital efficiency is deteriorating. Negative free cash flow of -SGD 11M. The business is consuming cash, not generating it.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
SGD 132K
▼ -21.2% YoY
Net Income (TTM)
-SGD 6M
▼ -19.9% YoY
Op. Margin
-4771.24%
▼ -2389.9pp YoY
ROIC
-165.47%
▼ -6.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-SGD 11M
▼ -181.0% YoY
Op. Cash Flow (TTM)
-SGD 11M
▼ -198.4% YoY
Net Debt
-SGD 311K
Net Cash Position
Cash & Equiv.
SGD 762K
3Y CAGR: -41.2%
Continue Research
Is Phaos Technology Holdings (Cayman) (POAS) overvalued?
Phaos Technology Holdings (Cayman) (POAS)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Phaos Technology Holdings (Cayman) scores 18/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Phaos Technology Holdings (Cayman) a high-quality business?+
Phaos Technology Holdings (Cayman) scores 18 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -4,771.2% operating margin and a -165.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Phaos Technology Holdings (Cayman) a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh POAS's valuation and scores 18/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Medical Devices
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.